Literature DB >> 33254014

MicroRNA-217: A regulator of human cancer.

Shuai Zhou1, Chao Zhu2, Qing Pang3, Hui Chun Liu4.   

Abstract

As highly conserved non-coding RNAs of approximately 18-24 nucleotides, microRNAs (miRNAs) regulate the expression of target genes. Multiple studies have demonstrated that miRNAs participate in the regulation of human cancer. MircoRNA-217 (miR-217) participates in the regulation of various tumors by specifically binding target genes and post-transcriptional regulation. In recent years, there have been numerous reports about miR-217 in tumor progression. MiR-217 is known mainly as a tumor suppressor, although some studies have shown that it functions as an oncomiR. Here, we review the current research related to miR-217, including its role in tumor progression and the molecular mechanisms.
Copyright © 2020. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Cancer; Target gene; Tumor suppressor miRNA; mircoRNA-217; oncomiR

Mesh:

Substances:

Year:  2020        PMID: 33254014     DOI: 10.1016/j.biopha.2020.110943

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  3 in total

1.  Comprehensive competitive endogenous RNA network analysis reveals EZH2-related axes and prognostic biomarkers in hepatocellular carcinoma.

Authors:  Mohammad Hossein Donyavi; Sadra Salehi-Mazandarani; Parvaneh Nikpour
Journal:  Iran J Basic Med Sci       Date:  2022-03       Impact factor: 2.532

2.  Comprehensive analysis of INHBA: A biomarker for anti-TGFβ treatment in head and neck cancer.

Authors:  Shunhao Zhang; Keyu Jin; Tianle Li; Maolin Zhou; Wenbin Yang
Journal:  Exp Biol Med (Maywood)       Date:  2022-05-06

Review 3.  MiRNAs and Cancer: Key Link in Diagnosis and Therapy.

Authors:  Yu Shi; Zihao Liu; Qun Lin; Qing Luo; Yinghuan Cen; Juanmei Li; Xiaolin Fang; Chang Gong
Journal:  Genes (Basel)       Date:  2021-08-23       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.